Diseases /
Head and Neck Neuroendocrine Carcinoma
Overview
Head and neck neuroendocrine carcinomas most frequently harbor alterations in TP53, RB1, KMT2D, HRAS, and SMARCA4 [2].
TP53 Mutation, KMT2D Mutation, RB1 Nonsense, RB1 Mutation, and HRAS Mutation are the most common alterations in head and neck neuroendocrine carcinoma [2].
Clinical Trials
Disease Details
References
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.